Intracranial haemorrhage and use of selective serotonin reuptake inhibitors.
about
Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysisSelective serotonin re-uptake inhibitors and the risk of bleedingClinical impact of selective serotonin reuptake inhibitors therapy with bleeding risksUse of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarctionSelective serotonin reuptake inhibitors and gastrointestinal bleeding: a case-control study.Epidemiology and treatment of post-stroke depression.Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretationEffects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients.The use of antidepressants and the risk of haemorrhagic stroke: a nested case control studyMonoamine depletion by reuptake inhibitors.Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched studyIs it safe to use antidepressants after a stroke?Antidepressants and risk of upper gastrointestinal bleeding.Use of Selective Serotonin Reuptake Inhibitors and Risks of Stroke in Patients with Obsessive Compulsive Disorder: A Population-Based Study.Poststroke depression: a review emphasizing the role of prophylactic treatment and synergy with treatment for motor recovery.Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis.Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patients.Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: a meta-analysis of observational studies.Risk of Bleeding in Patients on Full-Dose Enoxaparin With Venous Thromboembolism and Selective Serotonin Reuptake Inhibitors.Preadmission use of selective serotonin reuptake inhibitors and short-term mortality in diabetic patients hospitalized due to stroke.Use of serotonergic drugs and the risk of bleeding.SSRI treatment-associated stroke: causality assessment in two cases.Bruising associated with sibutramine: results from postmarketing surveillance in New Zealand.Bleeding adverse drug reactions (ADRs) in patients exposed to antiplatelet plus serotonin reuptake inhibitor drugs: analysis of the French Spontaneous Reporting Database for a controversial ADR.Sertraline-induced periorbital purpura: a case report.
P2860
Q28196269-110BE55D-9613-4C9D-BF99-7504174AC1A5Q28211440-9CE4821D-EE39-4B62-8EB6-908C6F5EE035Q28219114-BBE6AE39-40EF-4FE2-ACBF-2CC151F05FEBQ28345555-B0CEE0F6-7E84-4AE3-973D-BF1A391D8F6EQ33916845-618FAD14-7A6A-49DD-9462-78494A560216Q34013538-2A2A4B17-A06E-44F8-A499-F06C374C9E2AQ34025768-460F4E2E-5087-4CA9-BD33-8ECAE750846DQ34182611-0519C940-2159-4049-8E5E-B51FF3FEADBCQ34476123-0C520327-E9DF-4612-A919-3FD249D804FBQ35611437-281D34C7-D3D3-429F-93CD-4C3BD03EB04CQ35849142-5ED972E8-D04D-4070-B863-5C1C93020802Q36235515-D9A1AB26-18DD-4100-A2E4-0DE753BECC04Q36447534-AE9671CC-0F3A-499B-9047-B819A802484AQ37245217-1EBE5DF4-A7FD-492B-A297-592F45E1D8DEQ38101167-143AC90C-4E66-430E-9D60-328DD36BF9C7Q38183266-DCE1E946-0C49-4EC0-80B5-23C20F7F1AE3Q38402064-DBA1DC67-57C1-47E0-B2F2-8EE56234322DQ39077689-606DA67D-79A9-4EB1-97E1-827BDD165EEEQ40480045-01006D0D-00C8-4572-B87D-650E8EBF09CDQ40772245-FFDAEF53-7C85-4B0D-8CCA-1D9C31EE1E42Q44648860-A8E752B2-8DC7-4410-B7E9-0E96CD32A5BEQ44901300-1BA7FF01-20B0-41DE-BE3F-FD57B9A7EB7CQ46954612-66727EE8-88A7-45B9-8863-18EDF51AD282Q47864318-8E9599A7-3A2E-44A2-92E2-71275DFA2545Q51025625-DE71AC79-038C-4835-9CF9-EA1E63D051E8
P2860
Intracranial haemorrhage and use of selective serotonin reuptake inhibitors.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Intracranial haemorrhage and use of selective serotonin reuptake inhibitors.
@ast
Intracranial haemorrhage and use of selective serotonin reuptake inhibitors.
@en
type
label
Intracranial haemorrhage and use of selective serotonin reuptake inhibitors.
@ast
Intracranial haemorrhage and use of selective serotonin reuptake inhibitors.
@en
prefLabel
Intracranial haemorrhage and use of selective serotonin reuptake inhibitors.
@ast
Intracranial haemorrhage and use of selective serotonin reuptake inhibitors.
@en
P2093
P2860
P1476
Intracranial haemorrhage and use of selective serotonin reuptake inhibitors.
@en
P2093
P2860
P356
10.1046/J.1365-2125.2000.00216.X
P407
P577
2000-07-01T00:00:00Z